Impact of adverse news media on prescriptions for osteoporosis: effect on fractures and mortality

Paul J Sambrook, B E Christopher Nordin and Alastair N Goss
Med J Aust 2011; 194 (1): . || doi: 10.5694/j.1326-5377.2011.tb04153.x
Published online: 3 January 2011

To the Editor: The article by Philip Sambrook et al on the impact of adverse news media on prescriptions for osteoporosis1 contains a number of serious errors and ignores more recent data.

  • Paul J Sambrook1,2
  • B E Christopher Nordin1,2
  • Alastair N Goss2

  • 1 Royal Adelaide Hospital, Adelaide, SA.
  • 2 University of Adelaide, Adelaide, SA.

Competing interests:

Alastair Goss has been a consultant to Merck and Novartis on ONJ, and has provided expert testimony for the plaintiffs in the US class action against Merck with respect to alendronate.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.